By gating immature blast cells, we did not observe differences in the PPCs expressing typical markers of myeloid progenitor cells, such as CD13, CD33, CD117, CD123, and HLA-DR between diagnostic AML and MDS samples (Fig. 2A). This evidence concerns the gene ANPEP and acute myeloid leukemia.